Enabling patient
access to cell
therapy at scale
Latest news
Modular vs. End-to-End Automation in Cell and Gene Therapy Manufacturing: Finding the Right Fit
The field of cell and gene therapy manufacturing is revolutionising medicine, offering the potential to treat and even cure diseases once considered intractable. As these therapies move from research to commercialisation, the need for robust, scalable, and...
Industrialised cell therapy manufacturing - powered by partnership
Industrialised cell therapy manufacturing - powered by partnership
Enabling wider patient access to life-saving treatment
Cellular Origins is revolutionising cell therapy manufacturing, driving industrialisation and digitalisation at scale. By partnering with the industry’s leading technology and manufacturing innovators, we fully automate your existing processes and technologies within our advanced mobile robotic ecosystem, Constellation®. This enables us to deliver GMP-compliant, fully automated solutions for scaling cell therapy manufacturing, offering unparalleled efficiency, precision, and flexibility.
Enabling wider patient access to life-saving treatment
Cellular Origins is revolutionising cell therapy manufacturing, driving industrialisation and digitalisation at scale. By partnering with the industry’s leading technology and manufacturing innovators, we fully automate your existing processes and technologies within our advanced mobile robotic ecosystem, Constellation®. This enables us to deliver GMP-compliant, fully automated solutions for scaling cell therapy manufacturing, offering unparalleled efficiency, precision, and flexibility.
Scalable, automated cell therapy manufacturing
Streamlined automation, seamless integration of proven technologies, and scaling without altering your processes are vital for success. That’s why they are central to Cellular Origins’ approach. And why we’re transforming the future of cell therapy manufacturing.
The cell therapy industry is at a tipping point. As more life-saving therapies receive approval, the need to scale manufacturing has never been more urgent. Yet current approaches fall short—manual processes, labour shortages, and space constraints are holding back progress. These limitations create bottlenecks that threaten the industry’s ability to deliver therapies to every patient who needs them.
We see a different future—one driven by automation, digitisation, and flexibility. This is manufacturing reimagined: connected, flexible, and ready to meet the needs of today and tomorrow. Our solutions adapt to the specific requirements of each therapy, ensuring consistency, quality, and speed. By bridging the gap between innovation and industrialisation, we are building a foundation for the future of cell therapy—a future where treatments are delivered faster, more reliably, and at scale. At Cellular Origins, we are not just solving today’s challenges. We are transforming how cell therapies reach patients, at the scale the world demands.
Scalable, automated cell therapy manufacturing
Streamlined automation, seamless integration of proven technologies, and scaling without altering your processes are vital for success. That’s why they are central to Cellular Origins’ approach. And why we’re transforming the future of cell therapy manufacturing.
The cell therapy industry is at a tipping point. As more life-saving therapies receive approval, the need to scale manufacturing has never been more urgent. Yet current approaches fall short—manual processes, labour shortages, and space constraints are holding back progress. These limitations create bottlenecks that threaten the industry’s ability to deliver therapies to every patient who needs them.
We see a different future
A future driven by automation, digitisation, and flexibility. This is manufacturing reimagined: connected, flexible, and ready to meet the needs of today and tomorrow. Our solutions adapt to the specific requirements of each therapy, ensuring consistency, quality, and speed. By bridging the gap between innovation and industrialisation, we are building a foundation for the future of cell therapy—a future where treatments are delivered faster, more reliably, and at scale. At Cellular Origins, we are not just solving today’s challenges. We are transforming how cell therapies reach patients, at the scale the world demands.
Shift gear, not process
Clean room render based on Cell and Gene Therapy Catapult Stevenage Manufacturing Innovation Centre design.
Shift gear, not process
Clean room render based on Cell and Gene Therapy Catapult Stevenage Manufacturing Innovation Centre design.
Benefits of cell therapy automation
- Scalable flexibility (adopt at any stage)
- Labour reduction and efficiency
- Modularity and adaptability
- Integrating existing technology
- Innovative and future-proof
Cellular Origins offers unmatched flexibility – seamlessly integrating pipeline products and modular unit operations, physically and digitally, into a fully automated platform that fits effortlessly into any stage of your development process and scales with you as you grow. Furthermore, with Constellation, you can chose to scale-up at any stage of your process – whether that is early or late, at a time to suit you.
Constellation redefines cell therapy manufacturing by cutting labour by 16x, reducing errors, and boosting efficiency—all while maintaining regulatory confidence. With >30x space optimisation, you can increase production capacity without expanding footprint. Lower CoGs by 51% and eliminate re-validation needs with a fully automated, seamless robotic ecosystem.
Constellation’s free-roaming robots and modular design enable quick replacements of devices or robotics without disrupting 24/7 production. The built-in safety system allow human operators to move within the same space as needed, meaning no need for full shutdown during routine maintenance.
Constellation’s free-roaming robots and modular design enable quick replacements of devices or robotics without disrupting 24/7 production. The built-in safety system allow human operators to move within the same space as needed, meaning no need for full shutdown during routine maintenance.
Through partnership and advanced automation, Constellation is designed to handle both today’s therapies as well as future advancements. This ensures manufacturers can scale to meet evolving therapeutic demand.
Partnering for success
By partnering with proven leading technology providers, we are uniting the best devices and technologies into a single, seamlessly integrated platform. This collaboration ensures cell therapy developers benefit from a robotically connected and digitally managed ecosystem that is easy to install at any stage of development and operates flexibly, reliably and efficiently. The result? A coordinated solution that simplifies processes, reduces risks, and accelerates scalable manufacturing—empowering developers to focus on what matters most: delivering life-saving therapies to patients.
Partnering for success
By partnering with proven leading technology providers, we are uniting the best devices and technologies into a single, seamlessly integrated platform. This collaboration ensures cell therapy developers benefit from a robotically connected and digitally managed ecosystem that is easy to install at any stage of development and operates flexibly, reliably and efficiently. The result? A coordinated solution that simplifies processes, reduces risks, and accelerates scalable manufacturing—empowering developers to focus on what matters most: delivering life-saving therapies to patients.
News and events
Modular vs. End-to-End Automation in Cell and Gene Therapy Manufacturing: Finding the Right Fit
The field of cell and gene therapy manufacturing is revolutionising medicine, offering the potential to treat and even cure diseases once considered intractable. As these therapies move from research to commercialisation, the need for robust, scalable, and...
As featured in:
Sign up for updates
Stay up-to-date with Cellular Origins and receive all our latest developments!